Persistent URL of this record https://hdl.handle.net/1887/3249769
Documents
-
- Download
- s13075-021-02671-z
- Publisher's Version
-
open access
- Full text at publishers site
In Collections
This item can be found in the following collections:
Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution
- Date
- 2022-01-03
- Journal
- Arthritis Research and Therapy
- Volume
- 24
- Issue
- 1